{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:05Z","timestamp":1790777945464,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Piperonyl Butoxide Task Force II"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.tox.2020.152465","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T02:32:53Z","timestamp":1587263573000},"page":"152465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance"],"prefix":"10.1016","volume":"439","author":[{"given":"Brian G.","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey R.","family":"Chatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Osimitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2020.152465_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/pest.1993.1032","article-title":"Differences in induction of three P450 isozymes by piperonyl butoxide, sesame, safrole, and isosafrole","volume":"46","author":"Adams","year":"1993","journal-title":"Pest. Biochem. Physiol."},{"key":"10.1016\/j.tox.2020.152465_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-2797(93)90101-4","article-title":"Regulation of cytochrome P-450 isozymes by methylenedioxyphenyl compounds","volume":"86","author":"Adams","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2020.152465_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-1218(96)90116-0","article-title":"Lack of effect of piperonyl butoxide on unscheduled DNA synthesis in precision-cut human liver slices","volume":"371","author":"Beamand","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045259","article-title":"Use of fibrates and cancer risk: a systemic review and meta-analysis of 17 long-term randomized placebo-controlled trials","volume":"7","author":"Bonovas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2020.152465_bib0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0030","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2020.152465_bib0035","series-title":"Independent Pathology Review of Hepatic Tissues from the BRRC Mouse Oncogenicity Study with Piperonyl Butoxide (BRRC Report No. 91 NO 134)","author":"Butler","year":"1995"},{"key":"10.1016\/j.tox.2020.152465_bib0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1218(96)90113-5","article-title":"Lack of genotoxicity of piperonyl butoxide","volume":"371","author":"Butler","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/096032719801700607","article-title":"Oncogenicity studies of piperonyl butoxide in rats and mice","volume":"17","author":"Butler","year":"1998","journal-title":"Hum. Exptl. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"S1","key":"10.1016\/j.tox.2020.152465_bib0055","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12864-018-4834-3","article-title":"The whole transcriptome effects of the PPAR\u03b1 agonist fenofibrate on livers of hepatocyte humanized mice","volume":"19","author":"De la Rosa Rodriguez","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tox.2020.152465_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrfmmm.2005.02.004","article-title":"Comparison of the expression profiles induced by genotoxic and nongenotoxic agents in rat liver","volume":"575","author":"Ellinger-Ziegelbauer","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0009-2797(80)90005-8","article-title":"The induction of hepatic cytochrome P-450 in C57 BL\/10 and DBA\/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents","volume":"31","author":"Fennell","year":"1980","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2020.152465_bib0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/019262301753385979","article-title":"Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys","volume":"29","author":"Gold","year":"2001","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2020.152465_bib0095","series-title":"Piperonyl Butoxide. The Insecticide Synergist","first-page":"215","article-title":"Inhibition of resistance-related esterases by piperonyl butoxide in Helicoverpa armigera (Lepidoptera: Noctuidae) and Aphis gossypii (Hemiptera: Aphididae)","author":"Gunning","year":"1998"},{"key":"10.1016\/j.tox.2020.152465_bib0100","first-page":"22","article-title":"Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes","volume":"396\u2013397","author":"Haines","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2020.152465_bib0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00498254.2018.1437300","article-title":"Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16\u03b1-carbonitrile in wild-type and constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) knockout rats","volume":"49","author":"Haines","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2020.152465_bib0110","series-title":"Chronic Dietary Oncogenicity Study with Piperonyl Butoxide in CD-1 Mice","author":"Hermansky","year":"1993"},{"key":"10.1016\/j.tox.2020.152465_bib0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tox.2009.01.007","article-title":"Comparison of the effects of the synthetic pyrethroid metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes","volume":"258","author":"Hirose","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2020.152465_bib0120","series-title":"Piperonyl Butoxide. The Insecticide Synergist","first-page":"41","article-title":"Interactions of piperonyl butoxide with cytochrome P450","author":"Hodgson","year":"1998"},{"key":"10.1016\/j.tox.2020.152465_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1289\/ehp.9193247","article-title":"Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents","volume":"93","author":"Huff","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2020.152465_bib0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/00498259309059372","article-title":"Effect of treatment with pyrazine and some pyrazine derivatives on cytochrome P450 and some enzyme activities in rat Liver","volume":"23","author":"Japenga","year":"1993","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2020.152465_bib0140","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfaa017","article-title":"An evaluation of the human relevance of the liver tumours observed in female mice treated with permethrin based on mode of action","author":"Kondo","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","article-title":"A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer","volume":"23","author":"La Vecchia","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.tox.2020.152465_bib0150","series-title":"Biochemical Toxicology: A Practical Approach","first-page":"183","article-title":"Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism","author":"Lake","year":"1987"},{"key":"10.1016\/j.tox.2020.152465_bib0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2020.152465_bib0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00498259609046709","article-title":"Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices","volume":"26","author":"Lake","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2020.152465_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0300-483X(98)00085-7","article-title":"Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver","volume":"131","author":"Lake","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2020.152465_bib0175","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1073\/pnas.73.6.2043","article-title":"A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug","volume":"73","author":"Lazarow","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2020.152465_bib0180","series-title":"BRRC Mouse Oncogenicity Study 91 NO 134. Statistical Analysis of Incidence of Liver Tumours and Survival in Males Following Independent Pathology Peer Review (Butler 1995)","author":"Lee","year":"2013"},{"key":"10.1016\/j.tox.2020.152465_bib0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2020.152465_bib0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-2797(90)90075-X","article-title":"Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers","volume":"75","author":"Lubet","year":"1990","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.tox.2020.152465_bib0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1194\/jlr.M800226-JLR200","article-title":"The nuclear receptor CAR (NR113) regulates serum triglyceride levels under conditions of metabolic stress","volume":"50","author":"Maglich","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tox.2020.152465_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/0049825031000085960","article-title":"Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices","volume":"33","author":"Meredith","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2020.152465_bib0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00341018","article-title":"Factors influencing peroxisome proliferation in cultured rat hepatocytes","volume":"55","author":"Mitchell","year":"1984","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2131\/jts.42.773","article-title":"Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin","volume":"42","author":"Okuda","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"S1","key":"10.1016\/j.tox.2020.152465_bib0220","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/toxsci\/kfq338","article-title":"Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities","volume":"120","author":"Omiecinski","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408440902914014","article-title":"Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk","volume":"39","author":"Osimitz","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0230","series-title":"Casarett and Doull\u2019s Toxicology. The Basic Science of Poisons","first-page":"133","article-title":"Biotransformation of xenobiotics","author":"Parkinson","year":"2001"},{"key":"10.1016\/j.tox.2020.152465_bib0235","first-page":"1143","article-title":"Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters","volume":"51","author":"Parzefall","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2020.152465_bib0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","article-title":"Minimum data sets to establish a CAR-mediated mode of action for rodent liver tumors","volume":"96","author":"Peffer","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2020.152465_bib0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/faat.1997.2326","article-title":"Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats","volume":"38","author":"Phillips","year":"1997","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2020.152465_bib0250","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/carcin\/19.9.1521","article-title":"The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate","volume":"19","author":"Plant","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2020.152465_bib0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)09289-2","article-title":"Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver","volume":"50","author":"Ryu","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2020.152465_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-2797(97)00035-5","article-title":"Regulation of hepatic CYP1A isozymes by piperonyl butoxide and acenaphthylene in the mouse","volume":"105","author":"Ryu","year":"1997","journal-title":"Chem. Bio. Interact."},{"key":"10.1016\/j.tox.2020.152465_bib0265","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0192623313482055","article-title":"Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether","volume":"41","author":"Sakamoto","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2020.152465_bib0270","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2131\/jts.40.787","article-title":"Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide","volume":"40","author":"Sakamoto","year":"2015","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0090-9556(24)14914-8","article-title":"Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and \u2013nonresponsive mice","volume":"27","author":"Sakuma","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2020.152465_bib0280","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1172\/JCI35483","article-title":"A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response","volume":"118","author":"Scheer","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2020.152465_bib0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tiv.2016.08.006","article-title":"Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation","volume":"36","author":"Soldatow","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2020.152465_bib0290","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/mp9001552","article-title":"Transcriptional activation of PPAR\u03b1 by phenobarbital in the absence of CAR and PXR","volume":"6","author":"Tamasi","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2020.152465_bib0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0192623314544378","article-title":"Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-\u03b1","volume":"43","author":"Tateno","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2020.152465_bib0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1293\/tox.25.189","article-title":"Comparative histomorphological review of rat and human hepatocellular proliferative lesions","volume":"25","author":"Thoolen","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2020.152465_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.61.1.1","article-title":"Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital","volume":"61","author":"Ueda","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2020.152465_bib0310","series-title":". Piperonyl Butoxide. Review of a Series 83-2 Mouse Carcinogenicity Study. Evidence for Liver Carcinogenicity","author":"US EPA","year":"1993"},{"key":"10.1016\/j.tox.2020.152465_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1293\/tox.11.1","article-title":"Comparison of the induction profile of hepatic drug-metabolizing enzymes between piperonyl butoxide and phenobarbital in rats","volume":"11","author":"Watanabe","year":"1998","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2020.152465_bib0320","article-title":"Metazachlor: mode of action for rat liver tumour formation and human relevance","author":"Wiemann","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2020.152465_bib0325","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/c7tx00288b","article-title":"Case examples of an evaluation of the human relevance of the pyrethroids\/pyrethrins-induced liver tumours in rodents based on the mode of action","volume":"7","author":"Yamada","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","article-title":"Human hepatocytes support the hypertrophic but not the hyperplastic responses to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver","volume":"142","author":"Yamada","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2020.152465_bib0335","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C4TX00217B","article-title":"Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes","volume":"4","author":"Yamada","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2020.152465_bib0340","series-title":"Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics","first-page":"417","article-title":"Receptor-mediated regulation of cytochromes P450","author":"Yoshinari","year":"2008"},{"key":"10.1016\/j.tox.2020.152465_bib0345","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-2952(97)00476-0","article-title":"Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse","volume":"55","author":"Zaher","year":"1998","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:43:17Z","timestamp":1759534997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X20301049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":69,"alternative-id":["S0300483X20301049"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2020.152465","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2020.152465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152465"}}